A clinical study to find out the effect of homoeopathic medicines in the management of Depression along with supportive counseling

The efficacy of individualized homoeopathic medicines in the management of Major Depressive Disorder with supportive counseling- a double blind randomized placebo controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060416

Enrollment

Registered

2023-12-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F320- Major depressive disorder, singleepisode, mild Health Condition 2: F321- Major depressive disorder, singleepisode, moderate

Interventions

Intervention1: Group A- Individualized Homoeopathic medicines: Patients with major depressive disorder are divided into group A- individualized medicine group and group B- placebo group through random

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 18-60 yrs of both sexes 2. Patient presenting with symptoms of mild and moderate depressive disorder for at least 2 weeks duration and fulfilling the diagnostic criteria of DSM-V 3. Patients with Becks depression inventory score between 17-30

Exclusion criteria

Exclusion criteria: 1. Patients having suicidal ideation with a history of attempted suicide. 2. Patients with severe depressive disorders taking anti depressants and antipsychotics. 3. Any other psychiatric co morbidities 4. Alcohol abuse/any serious physical illness using conventional treatment.

Design outcomes

Primary

Measure	Time frame
The Hamilton Depression Rating Scale (HDRS) will be assessed every month. The outcome measurement will be done by comparing the Hamilton Depression Rating Scale scores of subjects of both group A and group B at baseline, 3rd month and 6th monthTimepoint: 6 months	—

Secondary

Measure	Time frame
The WHO QOL- BREF scale will be assessed at the baseline and 6th month of the study.Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDR R BHUVANESWARI

National Homoeopathy Research Institute in Mental Health

dr.r.bhuvaneswari2021@gmail.com8281475541

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026